Sort   by:  
 Page size 
UnknownOxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
Not available
S-EPMC5072430 | biostudies-literature
UnknownStructural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects.
Not available
S-EPMC6362594 | biostudies-literature
UnknownLessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors.
Not available
S-EPMC12840088 | biostudies-literature
UnknownDietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.
Not available
S-EPMC5511264 | biostudies-literature
UnknownSystematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
Not available
S-EPMC3431504 | biostudies-literature
TranscriptomicsOvarian cancer cell lines PEA1 in low glucose condition shows metabolism-driven inflammation
Transcription profiling by array of PEA1 cell lines in low glucose growth condition compared to normal growth condition
ORGANISM(S): Homo sapiens 
2016-05-25 | E-MTAB-3799 | biostudies-arrayexpress
UnknownProtocol for the development and multisite validation of the Quality of Dying and Death-Revised Global Version scale.
Not available
S-EPMC9328109 | biostudies-literature
UnknownUnsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Not available
S-EPMC6088408 | biostudies-literature
UnknownFunctional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening.
Not available
S-EPMC6522557 | biostudies-literature
UnknownA putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
Not available
S-EPMC4747185 | biostudies-literature
Sort   by:  
 Page size